Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).
This page lists clinical trials related to Corneal Disorders from the ClinicalTrials.gov database.
Trial Summary
- Total studies: 50
- Recruiting: 22
- Active, not recruiting: 2
- Completed: 16
- Other: 10
Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.
Recruiting Trials
NCT01209000 — Nephrotic Syndrome Study Network
| Status | Recruiting |
| Phase | N/A |
| Sponsor | University of Michigan |
| Enrollment | 1200 |
| Study Type | OBSERVATIONAL |
| Conditions | Minimal Change Disease (MCD); Membranous Nephropathy; Glomerulosclerosis, Focal Segmental |
| Interventions |
Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting for approximately 12% of prevalent end stage renal disease (ESRD) cases (2005) at an annual cost in the US of more than $3 billion. However, the clinical classification of these diseases is widely believed to be inade…
NCT03030755 — Corneal Elastography and Patient Specific Modeling
| Status | Recruiting |
| Phase | N/A |
| Sponsor | The Cleveland Clinic |
| Enrollment | 60 |
| Study Type | OBSERVATIONAL |
| Conditions | Cornea; Ectasia; Refractive Errors; Keratoconus |
| Interventions |
The goal of this research is to develop measurement tools and simulation technology for characterizing and predicting individual responses to corneal treatments and for advancing understanding of corneal ectasia risk factors. Patients who either 1) have keratoconus and are being evaluated for corneal crosslinking or 2) have refractive error and are being evaluated for refractive surgery procedu…
NCT05003986 — Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Travere Therapeutics, Inc. |
| Enrollment | 67 |
| Study Type | INTERVENTIONAL |
| Conditions | Focal Segmental Glomerulosclerosis; Minimal Change Disease; Immunoglobulin A Nephropathy; IgA Vasculitis; Alport Syndrome |
| Interventions | ; ; |
To evaluate the safety, efficacy and tolerability of sparsentan oral suspension and tablets, and assess changes in proteinuria after once-daily dosing over 108 weeks.
NCT04571658 — NEPTUNE Match Study
| Status | Recruiting |
| Phase | N/A |
| Sponsor | University of Michigan |
| Enrollment | 375 |
| Study Type | INTERVENTIONAL |
| Conditions | Nephrotic Syndrome in Children; Focal Segmental Glomerulosclerosis; Minimal Change Disease; Minimal Change Nephrotic Syndrome; Membranous Nephropathy |
| Interventions |
NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.
NCT07634913 — Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Zhongshan Ophthalmic Center, Sun Yat-sen University |
| Enrollment | 3000 |
| Study Type | OBSERVATIONAL |
| Conditions | Artifical Intelligence; Cataract; Pterygium; Keratopathy; Subconjunctival Hemorrhage |
| Interventions |
This is a multi-center, cross-sectional study evaluating a smartphone-based artificial intelligence (AI) system for anterior segment eye disease screening. The system is designed to identify 16 clinically important anterior segment conditions from images captured using a standard Android smartphone. A core design feature of the system is that all image analysis is performed entirely on the smar…
NCT06291818 — Self-Adhering Magnetic Device to Treat Corneal Exposure
| Status | Recruiting |
| Phase | N/A |
| Sponsor | University of Illinois at Chicago |
| Enrollment | 25 |
| Study Type | INTERVENTIONAL |
| Conditions | Paralytic Lagophthalmos; Corneal Exposure |
| Interventions |
Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. W…
NCT06859411 — Prognosis of Posterior Lamellar Keratoplasty
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Centre Hospitalier Régional Metz-Thionville |
| Enrollment | 1000 |
| Study Type | OBSERVATIONAL |
| Conditions | Fuchs’ Endothelial Corneal Dystrophy; Pseudophakic Bullous Keratopathy |
| Interventions |
Over the past decade, the management of Fuchs’ endothelial corneal dystrophy (FECD) and pseudophakic bullous keratopathy (PBK) has been revolutionized by the development of posterior lamellar keratoplasty techniques: DSAEK and DMEK.
DSAEK (Descemet Stripping Automated Endothelial Keratoplasty) involves replacing the patient’s endothelium and pathological descemetum with a descemetic endothelia…
NCT06491615 — National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Eye Institute (NEI) |
| Enrollment | 1000 |
| Study Type | OBSERVATIONAL |
| Conditions | Inherited Ophthalmic Diseases; Hypopigmentation Disorder; Corneal Dystrophy; Blue-cone Monochromacy; Best Disease |
Background:
The eyeGENE (Registered Trademark) program is a research resource for inherited eye conditions which includes genotypic and phenotypic data, imaging, and a corresponding biobank of DNA samples from people with a variety of eye diseases. Since 2007 this registry has been helping researchers learn more about the genetic sources for many inherited eye diseases. These findings helped t…
NCT07605221 — Nomogram for Astigmatism Correction of KLEx
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Tianjin Eye Hospital |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Astigmatism |
| Interventions |
The goal of this clinical trial is to learn if nomogram could promote treatment outcomes in astigmatism correction. The main question it aims to answer is:
does the nomogram could promote treatment outcomes in astigmatism correction? If there is a comparison group: Researchers will compare non-nomogram adopted to see if the outcome acceptable.
Participants will ask to complete 3-month follow-…
NCT06895902 — Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy
| Status | Recruiting |
| Phase | Early Phase 1 |
| Sponsor | University of Alberta |
| Enrollment | 10 |
| Study Type | INTERVENTIONAL |
| Conditions | Facial Nerve Palsy; Corneal Exposure; Paralytic Lagophthalmos |
| Interventions |
The eyelids protect the cornea and eyelid closure is essential to ocular health and clear vision.
Patients with permanent Bells palsy or facial nerve palsy from other reasons such as tumours or trauma may be unable to blink and protect their cornea.
Irreversible visual loss can occur if the cornea is not kept lubricated.
Current treatment options for patients whose eyelid blink does not reco…
NCT06983028 — Atacicept in Multiple Glomerular Diseases
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Vera Therapeutics, Inc. |
| Enrollment | 250 |
| Study Type | INTERVENTIONAL |
| Conditions | pMN; IgAN; Nephrotic Syndrome; MCD; FSGS |
| Interventions |
A study to find how well atacicept works and how safe it is in participants with autoimmune kidney disease.
NCT06658002 — Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | University of California, San Francisco |
| Enrollment | 150 |
| Study Type | INTERVENTIONAL |
| Conditions | Fungal Keratitis; Corneal Ulcer |
| Interventions | ; |
The goal of this clinical trial is to learn if adjunctive topical Cyclosporine A eye drops combined with standard of care topical Natamycin treatment improves vision outcomes in patients with fungal keratitis.
NCT07657858 — Effect of Dry Eye Treatment on Corneal Astigmatism Measurements
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Jin Yang |
| Enrollment | 400 |
| Study Type | INTERVENTIONAL |
| Conditions | Dry Eye; Cataract |
| Interventions |
This prospective single-center study evaluates the effect of dry eye disease and short-term ocular surface treatment on the agreement and repeatability of corneal astigmatism measurements in patients with age-related cataract. Participants undergoing preoperative cataract evaluation are classified into a control group or a dry eye disease group according to ocular surface symptoms and objective…
NCT07368959 — AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Aurion Biotech |
| Enrollment | 120 |
| Study Type | INTERVENTIONAL |
| Conditions | Corneal Edema; Corneal Endothelial Dysfunction; Fuchs Endothelial Corneal Dysfunction; Pseudophakic Bullous Keratopathy (PBK) |
| Interventions | ; |
The purpose of this study is to assess the efficacy and safety of single injection dose of AURN001 compared with placebo in adult participants with corneal edema secondary to corneal endothelial dysfunction.
NCT07435142 — A Single-Center Clinical Study to Evaluate the Efficacy and Safety of Autologous Urine-Derived Epithelial Cells in the Treatment of Corneal Endothelial Cell Dysfunction
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Suxia Li |
| Enrollment | 3 |
| Study Type | INTERVENTIONAL |
| Conditions | Cornea Disease |
| Interventions |
Corneal endothelial cell dysfunction is usually a corneal disease caused by damage or loss of corneal endothelial cells. It is characterized by corneal edema, opacity, and subepithelial bullae, leading to pain, blurred vision, or even blindness. Conventional treatments usually involve allogeneic corneal transplantation or corneal endothelial transplantation. Anterior chamber cell transplantatio…
NCT07605572 — Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Attikon Hospital |
| Enrollment | 100 |
| Study Type | OBSERVATIONAL |
| Conditions | Dry Eye Disease (DED); Diabete Mellitus; GLP-1; Ocular Surface; Diabetes Type 2 |
Diabetes mellitus (DM), prediabetes, and obesity are emerging as major global public health problems, with their epidemic spread continuously increasing over the past decades. The occurrence of diabetic retinopathy, cataract, glaucoma, and ocular surface disease in patients with diabetes mellitus has been extensively investigated in several studies. However, mild ocular surface disorders, such …
NCT07642960 — Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization
| Status | Recruiting |
| Phase | N/A |
| Sponsor | HoChiMinh City Eye Hospital |
| Enrollment | 51 |
| Study Type | INTERVENTIONAL |
| Conditions | Corneal Neovascularisation |
| Interventions | ; |
The goal of this clinical trial is to evaluate the efficacy and safety of combined fine-needle diathermy and subconjunctival Bevacizumab injection in patients with corneal neovascularization.
The main questions it aims to answer are:
Does combined fine-needle diathermy and subconjunctival Bevacizumab injection promote regression of corneal neovascularization? Is the treatment safe and well to…
NCT07629557 — Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Glaukos Corporation |
| Enrollment | 15 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconus |
| Interventions | ; |
Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.
NCT07539012 — Effect of Descemet Membrane Polishing in Fuchs Endothelial Corneal Dystrophy
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Enrollment | 20 |
| Study Type | INTERVENTIONAL |
| Conditions | Fuchs Endothelial Corneal Dystrophy |
| Interventions |
Fuchs endothelial corneal dystrophy (FECD) is the leading indication for corneal transplantation worldwide. It is characterized by the accumulation of guttae and progressive loss of corneal endothelial cells, leading to corneal edema and visual impairment. Endothelial keratoplasty remains the standard treatment; however, graft shortages have driven the development of cell-based therapies involv…
NCT07636590 — Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Claris Biotherapeutics, Inc. |
| Enrollment | 500 |
| Study Type | OBSERVATIONAL |
| Conditions | Limbal Stem Cell Deficiency |
| Interventions |
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
NCT07224529 — Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | University of Alabama at Birmingham |
| Enrollment | 48 |
| Study Type | INTERVENTIONAL |
| Conditions | Meibomian Gland Dysfunction (MGD) |
| Interventions |
This research study evaluates a prescription eye drop called Vevye® (cyclosporine 0.1%) for adults who have meibomian gland dysfunction (MGD), a common eye condition that can cause dry, irritated, or burning eyes.
If you join the study, after a short “run-in” period using artificial tears, you will receive Vevye twice a day for about 24 weeks (approximately six months). During that time you wi…
NCT07519902 — An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Dompé Farmaceutici S.p.A |
| Enrollment | 150 |
| Study Type | INTERVENTIONAL |
| Conditions | Persistent Corneal Epithelial Defect |
| Interventions | ; |
This is a phase 3, randomized, multicenter, double-masked, parallel group, vehicle-controlled prospective clinical trial to evaluate the safety and efficacy of cenegermin in inducing complete epithelial healing in participants with PCED. The primary objective is the evaluation of complete epithelial healing after 4 weeks of treatment. The study is comprised of 3 periods: an 8-week initial treat…
Active, Not Recruiting
NCT00092222 — Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Sponsor | National Cancer Institute (NCI) |
| Enrollment | 75 |
| Study Type | INTERVENTIONAL |
| Conditions | Lymphoproliferative Disorder; HHV-8; Malignancy; HIV |
| Interventions | ; ; |
This study will gain information about a rare disorder called KSHV-associated multicentric Castleman’s disease (MCD). KSHV, a virus, causes several kinds of cancer, including some forms of MCD. KSHV stands for the Kaposi’s sarcoma herpes virus, also called human herpes virus-8, or HHV-8. Researchers want to understand the biology of KSHV-MCD to identify how this disease causes illness and to fi…
NCT00560651 — German Corneal Cross Linking Register
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | Suphi Taneri |
| Enrollment | 356 |
| Study Type | OBSERVATIONAL |
| Conditions | Keratoconus |
| Interventions |
Corneal Cross Linking is new treatment modality for patients with keratoconus. A keratoconus is characterized by progressive bulging and thinning of the eye’s cornea. Keratoconus is a potentially severely sight impairing condition that may necessitate corneal transplantation in the progressive state.
Corneal Cross Linking is designed to
- increase the cornea’s mechanical stability
- to stop p…
Not Yet Recruiting
NCT07638215 — A Single-Center Clinical Study to Evaluate the Efficacy and Safety of Sutureless Ophthalmic Hydrogel for Corneal Wound Repair
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Suxia Li |
| Enrollment | 30 |
| Study Type | INTERVENTIONAL |
| Conditions | Corenal Diseases |
| Interventions |
Corneal blindness is one of the leading causes of blindness worldwide. For various infectious and non-infectious corneal diseases, current clinical repair strategies include corneal lesion debridement, conjunctival flap coverage, amniotic membrane transplantation, corneal transplantation, contact lens application, and injectable sealants. Injectable hydrogels, as smart materials that transition…
NCT07608367 — A Single-Center Clinical Study to Evaluate the Efficacy and Safety of a Suture-Free Ophthalmic Hydrogel for Ocular Surface Tissue Adhesion
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Suxia Li |
| Enrollment | 20 |
| Study Type | INTERVENTIONAL |
| Conditions | Cornea Disease |
| Interventions |
When severe ocular surface lesions occur (e.g., pterygium, corneal ulcer, ocular surface burn, etc.), the currently clinically common surgical procedures such as conjunctival flap coverage, amniotic membrane transplantation, and keratoplasty are primarily fixed by suturing. However, suturing has numerous drawbacks. On the one hand, the suturing process causes additional mechanical damage to ocu…
NCT07657143 — Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma
| Status | Not yet recruiting |
| Phase | Phase 4 |
| Sponsor | London School of Hygiene and Tropical Medicine |
| Enrollment | 12 |
| Study Type | INTERVENTIONAL |
| Conditions | Survival of Flies Developing in Faecal Samples |
| Interventions |
Trachoma is caused by repeated Chlamydia trachomatis infection in the eye. Routes of infection include close person-to-person contact and contaminated clothing. In addition, the bazaar fly Musca sorbens has been implicated in transmission. These flies frequently visit the faces of children and have been found positive for C. trachomatis, which may be transferred from the body of the flies or th…
NCT07647146 — Corneal Epithelial Thickness Mapping by Anterior Segment Optical Coherence Tomography in Patients With Refractive Errors
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Sohag University |
| Enrollment | 360 |
| Study Type | OBSERVATIONAL |
| Conditions | Myopia; Hyperopia; Astigmatism; Emmetropia |
This study evaluates corneal epithelial thickness using anterior segment optical coherence tomography (AS-OCT) in patients with refractive errors. It aims to assess the relationship between epithelial thickness patterns and different types of refractive errors.
NCT07623837 — Clinical Validation of AI-Based Quantitative Eye Movement Analysis From Smartphone 9-Gaze Videos (Glandy EOM)
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | THYROSCOPE INC. |
| Enrollment | 1000 |
| Study Type | OBSERVATIONAL |
| Conditions | Ocular Motility Disorders; Strabismus; Extraocular Muscle Dysfunction; Thyroid Eye Disease |
| Interventions |
This prospective, multicenter, multinational observational study evaluates the clinical validity of an AI-based quantitative eye movement analysis system (Glandy EOM) that analyzes smartphone-recorded 9-gaze videos. Approximately 200 adults per site with suspected or confirmed ocular motility abnormalities will undergo a single study visit consisting of a standard clinical 9-gaze examination, a…
NCT07599020 — Measuring the Changes of the Intraocular Pressure After Corneal Cross Linking Using Corvis CT
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Tanta University |
| Enrollment | 1 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconus; Intraocular Pressure |
| Interventions |
To evaluate the changes that occur in the intraocular pressure before and after corneal cross linking using Corvis CT.
NCT07614360 — Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Sponsor | GlaxoSmithKline |
| Enrollment | 150 |
| Study Type | INTERVENTIONAL |
| Conditions | Multiple Myeloma |
| Interventions | ; ; |
The aim of this study is to assess safety, efficacy and pharmacokinetic (PK) parameters with alternative dosing schedules of belantamab mafodotin in combination with bortezomib and dexamethasone compared to the approved dosing regimen in participants with relapsed or refractory multiple myeloma (RRMM) who have received at least 2 prior lines of therapy. The study will further characterize the r…
NCT07623317 — Can Tailored Surgical Incisions Reduce Refractive Error and Dependence on Glasses After Cataract Surgery?
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Linkoeping University |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Cataract (Post-operative Cataract Surgery Follow-up); Refraction Error |
| Interventions |
Astigmatism is a common cause of continued dependence on glasses after cataract surgery and may lead to patient dissatisfaction with surgical outcomes. As the corneal curvature is the main source for astigmatism after cataract surgery, our aim is to investigate whether postoperative astigmatism can be reduced by tailoring the location of surgical incisions according to the curvature of the corn…
NCT07559188 — Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Azalea Vision |
| Enrollment | 16 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconus; Presbyopia; Scleral Contact Lenses; Pinhole |
| Interventions | ; |
The purpose of this clinical study is to evaluate the effectiveness of the NOA lens, a custom-made scleral contact lens developed by Azalea Vision BV, in improving visual quality for individuals with keratoconus and presbyopia.
This clinical study investigates a new lens design featuring a specific central aperture (opening) intended to enhance image quality by increasing depth of focus and re…
NCT07308938 — Fluorometholone Study
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Sponsor | Vishal Jhanji |
| Enrollment | 174 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratitis Bacterial; Corneal Ulcer (Diagnosis) |
| Interventions | ; |
The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with bacterial corneal ulcers compared with standard topical antibiotic therapy alone.
Completed Trials
NCT00201955 — Study of Rebamipide Eye Drops to Treat Dry Eye
| Status | Completed |
| Phase | Phase 3 |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Enrollment | 762 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconjunctivitis Sicca |
| Interventions | ; ; |
The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).
NCT00201981 — A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a Placebo
| Status | Completed |
| Phase | Phase 3 |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Enrollment | 755 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconjunctivitis Sicca |
| Interventions | ; ; |
The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).
NCT00845117 — Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency
| Status | Completed |
| Phase | N/A |
| Sponsor | Veerle Van Gerwen |
| Enrollment | 21 |
| Study Type | INTERVENTIONAL |
| Conditions | Limbal Stem Cell Deficiency |
| Interventions |
The purpose of this study is to determine whether cultivated stem cell transplantation is effective for the treatment of patients wtih corneal stem cell deficiency.
NCT02754583 — Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
| Status | Completed |
| Phase | Phase 3 |
| Sponsor | University of California, San Francisco |
| Enrollment | 47605 |
| Study Type | INTERVENTIONAL |
| Conditions | Trachoma |
| Interventions | ; ; |
SWIFT I is a series of 3 cluster-randomized trials designed to assess several alternative strategies for trachoma control in communities that have been treated with many years of mass azithromycin distributions. The first trial (named WUHA) compares communities that receive a comprehensive Water, Sanitation, and Hygiene (WASH) package to those that receive no intervention. The second trial (nam…
NCT04418999 — Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
| Status | Completed |
| Phase | Early Phase 1 |
| Sponsor | Illinois College of Optometry |
| Enrollment | 36 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconus; Dry Eye; Allergy |
| Interventions | ; |
Drug delivery platforms are an innovative exciting advancement in ophthalmology. They allow patients to eliminate topical medications which are generally associated with lack of compliance, difficulty of use and requiring help from family members. These delivery systems can be applied easily in office, and patients do not have to worry about drop insertion in their post-operative regimen.
The …
NCT04517903 — Validation Study on Eye Rubbing Questionnaire in Patients With or Suspected of Having a Keratoconus (KC)
| Status | Completed |
| Phase | N/A |
| Sponsor | University Hospital, Bordeaux |
| Enrollment | 292 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconus |
| Interventions |
KC is a degenerative disorder of the cornea. Keratoconus etiopathogenesis remains unclear and may rely on environmental and genetic factors. Usually considered as a rare disease (<1/2000), but the prevalence is nowadays growing worldwide up to 1/500. In that pathology, cornea progressively gets thinner, and there is a deformation of the corneal surface which can induce high order optical aberr…
NCT07588074 — Tolerability Comparison of Flarex to Lotemax SM
| Status | Completed |
| Phase | Phase 4 |
| Sponsor | Harrow Inc |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | Ocular Inflammation; Keratoconjunctivitis; Dry Eye Disease (DED); Post-operative Complications; Kerato Conjunctivitis Sicca |
| Interventions | ; |
This study compared the ocular tolerability of fluorometholone acetate ophthalmic suspension 0.1% (FLAREX) to loteprednol etabonate ophthalmic gel 0.38% (Lotemax SM) in adult subjects. Each subject received one drop of each product, one in each eye, in a randomized, double-masked design. Comfort, impact on vision, and palpebral conjunctival injection were evaluated at 30 seconds, 5 minutes, and…
NCT05795699 — A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
| Status | Completed |
| Phase | Phase 3 |
| Sponsor | Kowa Research Institute, Inc. |
| Enrollment | 107 |
| Study Type | INTERVENTIONAL |
| Conditions | Fuchs Endothelial Corneal Dystrophy |
| Interventions | ; |
A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
NCT06100939 — Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
| Status | Completed |
| Phase | Phase 3 |
| Sponsor | Epion Therapeutics |
| Enrollment | 396 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconus |
| Interventions | ; |
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
NCT06100952 — Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
| Status | Completed |
| Phase | Phase 3 |
| Sponsor | Epion Therapeutics |
| Enrollment | 398 |
| Study Type | INTERVENTIONAL |
| Conditions | Keratoconus |
| Interventions | ; |
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
NCT06960629 — The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK)
| Status | Completed |
| Phase | Phase 2 / Phase 3 |
| Sponsor | University Hospital Dubrava |
| Enrollment | 50 |
| Study Type | INTERVENTIONAL |
| Conditions | Pseudophakic Bullous Keratopathy; Glaucoma |
| Interventions | ; |
The goal of this clinical trial is to learn if topical netarsudil/latanoprost works to treat pseudophakic bullous keratopathy in patients with glaucoma. The main questions it aims to answer are:
Does topical netarsudil/latanoprost improves visual function in patients with glaucoma and pseudophakic bullous keratopathy? Does topical netarsudil/latanoprost affects the central corneal thickness (C…
NCT06818461 — Assessment of Corneal Biomechanical Properties Using Corvis ST and ECD Following LASIK, PRK, CXL, Veriflex IOL and Implantable Collamer Lens
| Status | Completed |
| Phase | N/A |
| Sponsor | Beni-Suef University |
| Enrollment | 150 |
| Study Type | OBSERVATIONAL |
| Conditions | Myopia; Keratoconus; Refractive Surgery |
| Interventions |
To evaluate corneal biomechanical changes using the Corvis ST and ECD in patients who have under-gone LASIK, PRK, corneal cross-linking (CXL), Veriflex IOL and ICL.
NCT06611670 — Outcomes of High vs Physiological Intraocular Pressure During Cataract Surgery Using ACTIVE SENTRY
| Status | Completed |
| Phase | N/A |
| Sponsor | Centre hospitalier de l’Université de Montréal (CHUM) |
| Enrollment | 31 |
| Study Type | INTERVENTIONAL |
| Conditions | Cataract; Cataract Surgery; Cataract Bilateral |
| Interventions | ; |
Cataract surgery is a widely performed procedure across the world that helps restore vision in many patients suffering from cataracts. Irrigation is an essential component of the surgery. Fluid is constantly circulated to help regulate temperature as heat is generated with ultrasound energy, to minimize tissue trauma, and to create an intraocular pressure (IOP) sufficient to keep the anterior c…
NCT07605273 — Comparison of 5% Hypertonic Saline Versus 3% Hypertonic Saline in Resolution of Post-operative Corneal Edema.
| Status | Completed |
| Phase | N/A |
| Sponsor | Muhammad Aamir Latif |
| Enrollment | 70 |
| Study Type | INTERVENTIONAL |
| Conditions | Corneal Edema |
| Interventions | ; |
There is a lack of data to determine the comparative advantages of 5% hypertonic saline and 3% hypertonic saline over the other. Hence, the current study was planned to determine their comparative effectiveness by comparing the change in means of central corneal thickness in the groups receiving 3% hypertonic saline and 5% hypertonic saline eyedrops developing post-phacoemulsification corneal e…
NCT07623720 — CorVision® 4-year Follow-up
| Status | Completed |
| Phase | N/A |
| Sponsor | Gemini Eye Clinic |
| Enrollment | 95 |
| Study Type | OBSERVATIONAL |
| Conditions | Presbyopia |
The objective of the study is to assess the long-term safety and effectiveness of the CorVision® microlens implanted in presbyopic patients for the management of management of presbyopia and near vision impairment. Approximately 100 patients in the Czech Republic will participate in this study. The study was reviewed and approved by an independent research ethics committee and also by the State…
NCT07195864 — Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the “Medicines in Special Situations” (Medicamentos en Situaciones Especiales) Program in Spain.
| Status | Completed |
| Phase | N/A |
| Sponsor | SIFI SpA |
| Enrollment | 23 |
| Study Type | OBSERVATIONAL |
| Conditions | Acanthamoeba Keratitis |
| Interventions |
The study will be a multicentric, retrospective, non-interventional medical chart review of patients with AK who initiated a treatment with 0.8 mg/ml polihexanide as part of the Spanish Medicines in Special Situations program, whether they fully completed the treatment or not.
Baseline date is defined as the date of 0.8 mg/ml polihexanide initiation. The Study Period for each patient will be c…